Bionano Genomics, Inc. Quarterly Costs and Expenses in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Bionano Genomics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2017 to Q3 2024.
  • Bionano Genomics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $35.5M, a 69.4% decline year-over-year.
  • Bionano Genomics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $116M, a 50.8% decline year-over-year.
  • Bionano Genomics, Inc. annual Costs and Expenses for 2023 was $225M, a 63.3% increase from 2022.
  • Bionano Genomics, Inc. annual Costs and Expenses for 2022 was $138M, a 70% increase from 2021.
  • Bionano Genomics, Inc. annual Costs and Expenses for 2021 was $81M, a 96% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $116M $35.5M -$80.5M -69.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $197M $19.6M -$21.9M -52.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $219M $33.9M -$5.97M -14.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $225M $27.4M -$11.9M -30.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $237M $116M +$82M +241% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $155M $41.5M +$8M +23.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $147M $39.9M +$9.11M +29.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $138M $39.3M +$10.3M +35.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $127M $34M +$12.1M +55.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $115M $33.6M +$15.6M +87.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $99.6M $30.8M +$18.6M +152% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $81M $29M +$16.7M +136% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $64.3M $21.8M +$10.9M +99.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $53.4M $17.9M +$9.9M +124% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $43.5M $12.2M +$2.16M +21.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $41.3M $12.3M +$4.05M +49% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $37.3M $11M +$4.34M +65.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $32.9M $8.01M +$550K +7.37% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $32.4M $10M +$3.15M +45.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $29.2M $8.26M +$1.13M +15.9% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-10
Q3 2019 $28.1M $6.62M +$894K +15.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $27.2M $7.46M +$1.88M +33.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $25.3M $6.89M +$1.63M +30.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-18
Q4 2018 $23.7M $7.12M +$536K +8.13% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $23.2M $5.73M -$355K -5.83% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 $23.5M $5.59M -$1.73M -23.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 $25.3M $5.26M -$1.44M -21.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 $26.7M $6.59M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $6.08M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 $7.32M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 $6.7M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.